Clinical Trials Directory

Trials / Completed

CompletedNCT01138774

Effects of Lipoic Acid and Eicosapentaenoic Acid (EPA) in Human Obesity

Cellular and Molecular Effects of Lipoic Acid and Eicosapentaenoic Acid (EPA) on Adipose Tissue: Potential Application in Human Obesity

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
103 (actual)
Sponsor
Clinica Universidad de Navarra, Universidad de Navarra · Academic / Other
Sex
Female
Age
20 Years – 45 Years
Healthy volunteers
Accepted

Summary

The aim of the study is to analyze the effects of Lipoic acid and/or EPA supplementation on weight loss, lipid profile, insulin resistance, oxidative and inflammation parameters, metabolomic profile as well as on adipose tissue gene profile in healthy overweight/obese subjects following an energy-restricted diet.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTDouble blind dietary intervention with EPA and lipoic acidPlacebo-controlled dietary intervention during 10 weeks. All groups will have a dietary treatment with a calorie restriction of 30 % the subject's energy expenditure at baseline, supplemented with eicosapentaenoic acid (EPA) and/or lipoic acid (LA).

Timeline

Start date
2010-01-01
Primary completion
2011-12-01
Completion
2012-12-01
First posted
2010-06-07
Last updated
2015-05-28

Locations

1 site across 1 country: Spain

Source: ClinicalTrials.gov record NCT01138774. Inclusion in this directory is not an endorsement.